1. Home >
  2. M&A >
  3. Secondary Buyout >
  4. France >
  5. Eurazeo PME Acquires NeoXam

M&A Deal Summary

Eurazeo PME Acquires NeoXam

On November 21, 2022, private equity firm Eurazeo PME acquired software company NeoXam from Cathay Capital Private Equity and Bpifrance Investissement

Acquisition Highlights
  • This is Eurazeo PME’s 3rd transaction in the Software sector.
  • This is Eurazeo PME’s 54th transaction in France.

M&A Deal Summary
Date 2022-11-21
Target NeoXam
Sector Software
Buyer(s) Eurazeo PME
Sellers(s) Cathay Capital Private Equity
Bpifrance Investissement
Deal Type Secondary Buyout

Target

NeoXam

Paris, France
NeoXam is a provider of investment accounting, investment management, and data management software solutions. NeoXam's customer base is made of large and medium asset management firms, investment banks, institutional investors, and securities services providers. NeoXam was founded in 2014 and is based in Paris, France.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Eurazeo PME

Paris, France

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1997
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Eurazeo PME, formerly known as OFI Private Equity Capital. Eurazeo PME invests equity and mezzanine capital in secondary buyout transactions of unlisted French companies. The Firm looks for opportunities valued between €50 and €250 million. Areas of interest include chemicals, financial services, consumer services, retail, manufacturing, distribution, and life science. Eurazeo PME was formed in 1997 and is based in Paris.

DEAL STATS #
Overall 81 of 85
Sector: Software M&A 3 of 4
Type: Secondary Buyout M&A Deals 31 of 34
Country: France M&A 54 of 57
Year: 2022 M&A 10 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-07 NEST New York

New York, New York, United States

NEST New York is a designer and manufacturer of luxury home fragrances, personal care products and fine fragrances. Company offers a collection of over 30 home and fine fragrances sold in luxury department stores, specialty retailers and upscale boutiques, as well as on QVC and nestnewyork.com. NEST New York was founded in 2008 and is based in New York City.

Sell $200M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-03-09 Tennaxia

Changé, France

Tennaxia is a publisher of SaaS solutions to help listed companies and SMEs/mid-market companies in France with their CSR strategies. The company's mission is to help clients managing their CSR performance (Corporate Social Responsibility), facilitating their HSE governance EHS governance (Environment, Health, and Safety), reducing EHS risks and costs, complying with their main regulatory obligations, and anticipate stakeholder expectations. Tennaxia was founded in 2001 and is based in Changé, France.

Buy -

Seller(S) 2

SELLER

Cathay Capital Private Equity

Paris, France

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2006
PE ASSETS 5.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Cathay Capital Private Equity SAS is a French Chinese private equity firm focused on acquiring businesses in France, Hong Kong, and China. Cathay looks to help Western companies leverage opportunities in China and help Chinese companies leverage Western best practices and partnerships. The Firm looks to invest in businesses generating €5 to €150 million in revenues. Areas of interest include retail, consumer goods, electrical equipment, medical devices, pharmaceuticals, animal healthcare, translation, food, consumer services, and software. Cathay Capital Private Equity SAS was formed in 2007 and is based in Paris. The firm has additional offices in New York and Shanghai.

DEAL STATS #
Overall 24 of 31
Sector: Software M&A 1 of 1
Type: Secondary Buyout M&A Deals 12 of 15
Country: France M&A 16 of 21
Year: 2022 M&A 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-29 TransCure Bioservices

Archamps, France

TransCure Bioservices offering preclinical predictive in vivo pharmacology testing services to international large pharmaceutical, biotech and academic customers. TransCure Bioservices was founded in 2012 and is based in Archamps, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-12 Cenexi

Fontenay sous Bois, France

Cenexi engages in the contract manufacturing and packaging of pharmaceuticals for human and veterinary markets in the Americas, Asia, Oceania, Africa, and Europe. Cenexi was founded in 2004 and is based in Fontenay sous Bois, France.

Sell -
SELLER

Bpifrance Investissement

Category Private Equity Firm
Type Sector Agnostic
DESCRIPTION

DEAL STATS #
Overall 14 of 21
Sector: Software M&A 1 of 1
Type: Secondary Buyout M&A Deals 11 of 15
Country: France M&A 14 of 21
Year: 2022 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-14 Axess

Valence, France

Axess is positioned as a digital transformation expert, organised around three areas of expertise: publishing of vertical market software, cloud computing, and digital strategy services. Axess was founded in 2003 and is based in Valence, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-29 PCS

Paris, France

PCS is a financial services, that offers Mastercard-branded reloadable prepaid cards. It provides prepaid payment solutions without requiring a bank account and targets a broad customer base with a simple, accessible, and regulated product. PCS is based in Paris, France.

Buy -
Mergr

Solution for

Product

Company

Legal